REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Klinipak OOO (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Klinipak OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Klinipak OOO is an enterprise in Russia, with the main office in Moscow. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on February 02, 2011. 33 (2022) employees currently work for Klinipak OOO. In its most recent financial highlights, the company reported a net sales revenue increase of 16.57% in 2023. Its total assets grew by 81.47% over the same period. The net profit margin of Klinipak OOO decreased by 0.26% in 2023.

Headquarters
Vyborgskaya, 16, 1, XVI Kom.31
Moscow; Moscow; Postal Code: 125212

Contact Details: Purchase the Klinipak OOO report to view the information.

Website: http://klinipak.ru

Basic Information
Total Employees:
Purchase the Klinipak OOO report to view the information.
Outstanding Shares:
Purchase the Klinipak OOO report to view the information.
Registered Capital:
Purchase the Klinipak OOO report to view the information.
Incorporation Date:
February 02, 2011
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
36%
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Klinipak OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
16.57%▲
Total operating revenue
16.57%▲
Operating profit (EBIT)
10.46%▲
Net Profit (Loss) for the Period
15.1%▲
Total assets
81.47%▲
Total equity
51.02%▲
Operating Profit Margin (ROS)
-1.37%▼
Net Profit Margin
-0.26%▼
Return on Equity (ROE)
-10.54%▼
Debt to Equity Ratio
26.65%▲
Quick Ratio
-2.99%▼
Cash Ratio
-0.43%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo